Foreign pharmaceutical firms defy new positive list system

Published: 2006-06-19 06:58:00

Updated: 2006-06-19 06:58:00

Representatives of 26 multinational drug manufacturers of the Korean Research-based Pharmaceutical Industry Association (KRPIA) held a June 15 press conference against a new positive list system in Korea, claiming that it will ultimately bring negative effects for Korean patients.

They argued...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK